WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New ATC

List of new ATC codes decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC codes should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new ATC codes will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

Please note that the list does not include new ATC codes established as a result of ATC alterations.

ATC codeATC level name (INN/generic name)Deadline for objection to temporary code Implementation in the ATC/DDD index
A07DA06eluxadoline01.02.20162017
A16AA07metreleptin01.02.20162017
A16AX12trientine01.02.20162017
B01AF03edoxaban01.02.20162017
B03AB10ferric maltol01.02.20162017
C01EB23tiazotic acid01.02.20162017
C07AB14landiolol01.02.20162017
C07FX05metoprolol and ivabradine01.02.20162017
C07FX06carvedilol and ivabradine01.02.20162017
C10AX14alirocumab01.02.20162017
D11AX23aminobenzoate potassium01.02.20162017
D11AX24deoxycholic acid01.02.20162017
G03GA10follitropin delta01.02.20162017
G04BD13desfesoterodine01.02.20162017
H05BX04etelcalcetide01.02.20162017
J05AX68elbasvir and grazoprevir01.02.20162017
L01XC23elotuzumab01.02.20162017
L01XC24daratumumab01.02.20162017
L01XC25mogamulizumab01.02.20162017
L01XC26inotuzumab ozogamicin01.02.20162017
L01XE35osimertinib01.02.20162017
L01XE36alectinib01.02.20162017
L01XE37rociletinib01.02.20162017
L01XE38cobimetinib01.02.20162017
L01XX51talimogene laherparepvec01.02.20162017
L03AA16empegfilgrastim01.02.20162017
L04AC13ixekizumab01.02.20162017
M09AX05aceneuramic acid01.02.20162017
N02AJ14tramadol and dexketoprofen01.02.20162017
N04BD03safinamide01.02.20162017
P01BX02arterolane and piperaquine01.02.20162017
R03AK13salbutamol and beclometasone01.02.20162017
S01FB51phenylephrine and ketorolac01.02.20162017
V09IX09gallium (68Ga) endotreotide01.02.20162017
V09IX10fluoroethyl-L-tyrosine (18F)01.02.20162017

New ATC level codes (other than 5th levels)

ATC codeATC level nameDeadline for objection to temporary alterations Implementation in ATC/DDD index
A10BJGlucagon-like peptide-1 receptor (GLP-1) analogues01.02.20162017
A10BKSodium-glucose co-transporter 2 (SGLT2) inhibitors01.02.20162017
C07FXBeta blocking agents, other combinations01.02.20162017
N02AJOpioids in combination with non-opioid analgesics01.02.20162017

Last updated: 2015-12-18